High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer.

Of the 32 datasets with highly significant changes ( P ≤ 0.0001 and |lineal fold change (FC)| ≥ 2) (Fig. 1a ; Supplementary Table S1 ), 26 (81%) presented higher levels of SMARCA4 transcript in tumor samples than in non-tumor samples.

also in 132,142 other papers